Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Turgeon

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
European Journal of Clinical Pharmacology|August 11, 2001
Study of the drug-drug interaction between simvastatin and cisapride in manC Simard, G E O'Hara, J Prévost, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 20, 2011
[Focal dermal hypoplasia (Goltz syndrome) in the neonate: report of a case presenting with cleft lip and palate]K Nagalo, J-M Laberge, V-H Nguyen, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detectionJ Turgeon, H K Kroemer, C Prakash, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humansZ Abolfathi, C Fiset, M Gilbert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1992
Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deaminationJ Turgeon, J R Paré, M Lalande, et al.
Journal of Cardiovascular Pharmacology|April 25, 2000
Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemiaP Geelen, G E O'Hara, S Plante, et al.
Journal of Chromatographic Science|January 27, 1998
Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic studyE Lessard, A Fortin, A Coquet, et al.
Pharmacogenetics|January 14, 2000
Involvement of CYP2D6 activity in the N-oxidation of procainamide in manE Lessard, B A Hamelin, L Labbé, et al.
Pharmacogenetics|April 26, 2000
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humansE Lessard, M A Yessine, B A Hamelin, et al.
British Journal of Clinical Pharmacology|September 1, 1991
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Pharmacology|August 11, 2001
Study of the drug-drug interaction between simvastatin and cisapride in manC Simard, G E O'Hara, J Prévost, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 20, 2011
[Focal dermal hypoplasia (Goltz syndrome) in the neonate: report of a case presenting with cleft lip and palate]K Nagalo, J-M Laberge, V-H Nguyen, et al.
Journal of Pharmaceutical Sciences|February 1, 1990
Stereoselective determination of flecainide in human plasma by high-performance liquid chromatography with fluorescence detectionJ Turgeon, H K Kroemer, C Prakash, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1993
Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humansZ Abolfathi, C Fiset, M Gilbert, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1992
Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deaminationJ Turgeon, J R Paré, M Lalande, et al.
Journal of Cardiovascular Pharmacology|April 25, 2000
Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemiaP Geelen, G E O'Hara, S Plante, et al.
Journal of Chromatographic Science|January 27, 1998
Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic studyE Lessard, A Fortin, A Coquet, et al.
Pharmacogenetics|January 14, 2000
Involvement of CYP2D6 activity in the N-oxidation of procainamide in manE Lessard, B A Hamelin, L Labbé, et al.
Pharmacogenetics|April 26, 2000
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humansE Lessard, M A Yessine, B A Hamelin, et al.
British Journal of Clinical Pharmacology|September 1, 1991
Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.
Pageof 14